Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.01 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |